Efficacy of Combining an Extraoral High-Volume Evacuator with Preprocedural Mouth Rinsing in Reducing Aerosol Contamination Produced by Ultrasonic Scaling

Int J Environ Res Public Health. 2022 May 16;19(10):6048. doi: 10.3390/ijerph19106048.

Abstract

The coronavirus disease pandemic has afforded dental professionals an opportunity to reconsider infection control during treatment. We investigated the efficacy of combining extraoral high-volume evacuators (eHVEs) with preprocedural mouth rinsing in reducing aerosol contamination by ultrasonic scalers. A double-masked, two-group, crossover randomized clinical trial was conducted over eight weeks. A total of 10 healthy subjects were divided into two groups; they received 0.5% povidone-iodine (PI), essential oil (EO), or water as preprocedural rinse. Aerosols produced during ultrasonic scaling were collected from the chest area (PC), dentist's mask, dentist's chest area (DC), bracket table, and assistant's area. Bacterial contamination was assessed using colony counting and adenosine triphosphate assays. With the eHVE 10 cm away from the mouth, bacterial contamination by aerosols was negligible. With the eHVE 20 cm away, more dental aerosols containing bacteria were detected at the DC and PC. Mouth rinsing decreased viable bacterial count by 31-38% (PI) and 22-33% (EO), compared with no rinsing. The eHVE prevents bacterial contamination when close to the patient's mouth. Preprocedural mouth rinsing can reduce bacterial contamination where the eHVE is positioned away from the mouth, depending on the procedure. Combining an eHVE with preprocedural mouth rinsing can reduce bacterial contamination in dental offices.

Keywords: aerosols; dental office; essential oil; extraoral high-volume evacuator; oral bacteria; povidone-iodine; preprocedural mouth rinsing.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aerosols
  • Air Microbiology
  • Anti-Infective Agents, Local* / therapeutic use
  • Bacteria
  • Humans
  • Mouthwashes* / therapeutic use
  • Ultrasonics

Substances

  • Aerosols
  • Anti-Infective Agents, Local
  • Mouthwashes

Grants and funding

This work was supported by JSPS KAKENHI grant number JP19H03958 and JP21H03117. The funder, Japan Society for the Promotion of Science, had no role in study design, data collection and analysis, interpretation of data, and in writing the manuscript.